Aldagen And UC Davis Form Collaboration In Proprietary Regenerative Cell Therapies Related To Neural Diseases
Nov 7th 2008Drug InformationNeurology / Neuroscience
Aldagen, a North Carolina biopharmaceutical company developing proprietary regenerative cell therapies, and UC Davis Health System will collaborate to explore the activity of Aldagen’s unique adult stem cell population in a preclinical model of ischemic stroke. Adult stem cells hold promise in the treatment of this condition and other neurological disorders, including Parkinson’s disease, amyotrophic lateral sclerosis, traumatic brain injury and cerebral palsy.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
